Get startedLog in
    Picture of SpringWorks Therapeutics logo

    SWTX — SpringWorks Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapNeutral
    All News

    SpringWorks Therapeutics Inc expected to post a loss of $1.18 a share - Earnings Preview

    Picture of SpringWorks Therapeutics logoSpringWorks Therapeutics
    30/04/2024 16:52
    * SpringWorks Therapeutics Inc  SWTX.OQ   SWTX.O  is
expected
to show a rise in quarterly revenue when it reports  results on
May 2 for the period ending March 31 2024
    * The Stamford Connecticut-based  company is expected to
report
revenue of $12.206 million, according to the mean estimate from
7 analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for SpringWorks Therapeutics
Inc
is for a loss of $1.18 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 0.8%
in the last three months. ​
    * Wall Street's median 12-month price target for SpringWorks
Therapeutics Inc is $63.26​, above​ its last closing price
of $46.45. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jan. 1 0001   -1.24       -1.24      -1.45     Missed  -16.9
 Sep. 30 0001  -1.29       -1.33      -1.27     Beat    4.5
 Jun. 30 2023  -1.25       -1.26      -1.25     Beat    1​
 Mar. 31 2023  -1.31       -1.24      -1.18     Beat    5
 ​​Dec.        -1.22       -1.22      -1.17     Beat    4.2
 31 2022                                                
 Sep. 30 2022  -1.30       -1.32      -1.37     Missed  -3.8​
 Jun. 30 2022  -1.22       -1.20      -1.41     Missed  -17.2
 Mar. 31 2022  -1.07       -1.02      -1.26     Missed  -23.1
 This summary was machine generated April 30 at 15:51 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

    Recent news on SpringWorks Therapeutics

    See all news